Location · Boston, MA
Clinical trials in Boston, MA
787 recruiting studies have a site in the Boston area, and 318 of them accept healthy volunteers. The area includes Cambridge, Brookline, Newton, Waltham, Burlington, Chestnut Hill and nearby cities.
787 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Regeneron Pharmaceuticals
- Location
- Dothan, AL + 41 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sanofi
- Location
- Peoria, AZ + 126 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Novo Nordisk A/S
- Location
- Phoenix, AZ + 58 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
Shionogi
- Location
- Los Angeles, CA + 35 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
CVRx, Inc.
- Location
- Mobile, AL + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Zenas BioPharma (USA), LLC
- Location
- Phoenix, AZ + 24 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingPhase 2/Phase 3
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Bristol-Myers Squibb
- Location
- Loma Linda, CA + 11 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
AbbVie
- Location
- Phoenix, AZ + 9 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
Lumason® Infusion vs. Bolus Administrations
Bracco Diagnostics, Inc
- Location
- West Hills, CA + 3 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
SPYRAL GEMINI Pilot Study
Medtronic Vascular
- Location
- Stanford, CA + 11 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Boston Scientific Corporation
- Location
- Scottsdale, AZ + 46 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Merck Sharp & Dohme LLC
- Location
- Irvine, CA + 34 other US sites
- Eligibility basics
- Ages 50–85
- RecruitingPhase 3
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Alnylam Pharmaceuticals
- Location
- La Jolla, CA + 40 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 4
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Sanofi
- Location
- Birmingham, AL + 10 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 3
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
Sanofi
- Location
- Phoenix, AZ + 26 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Sanofi
- Location
- Fontana, CA + 20 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated…
Pulnovo Medical, Inc.
- Location
- Tucson, AZ + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
Transition to KPL-387 Monotherapy Dosing & Administration Study
Kiniksa Pharmaceuticals International, plc
- Location
- Phoenix, AZ + 20 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
Delivering tAN to Reduce HMB: The LUNA Study
Spark Biomedical, Inc.
- Location
- Boston, MA
- Eligibility basics
- Ages 14–45 · Women only
- RecruitingPhase 1/Phase 2
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
CRISPR Therapeutics AG
- Location
- Boston, MA + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Location
- Redlands, CA + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
Calico Life Sciences LLC
- Location
- Boston, MA + 2 other US sites
- Eligibility basics
- Ages 6 mo+
- RecruitingPhase 2
Strategy for Improving Stroke Treatment Response
Translational Sciences, Inc.
- Location
- Birmingham, AL + 37 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Sanofi
- Location
- Homewood, AL + 31 other US sites
- Eligibility basics
- Ages 18+